Schedule 13G ownership disclosure

Keros Therapeutics Inc

Security class unavailable · CUSIP: 492327101

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,392,402
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000128
Form type
SC 13G/A
Filer
ALKEON CAPITAL MANAGEMENT LLC
CIK
CIK 1230239
Filed
Feb 13, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub